CRT-704 Ultra-Hydrophilic Stents Promote Early Healing and Minimize Late Tissue Response: A Potential Alternative to Second-Generation Drug Eluting Stents

Late and Very Late Stent Thrombosis in the Era of Second-generation Drug-eluting Stents

Stent thrombosis is a life-threatening complication of percutaneous coronary intervention that often results in ST-segment myocardial infarction or sudden cardiac death. First-generation drug-eluting stents (DESs) are associated with an increased risk of late and very late stent thrombosis compared with baremetal stents due to delayed endothelialisation of the stent struts. The second-generatio...

Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.

OBJECTIVES This study sought to compare the risk of stent thrombosis among patients treated with bare-metal stents (BMS), first-generation drug-eluting stents (G1-DES), and second-generation drug-eluting stents (G2-DES) for a period of 3 years. BACKGROUND In patients undergoing coronary stenting, there is a scarcity of long-term follow-up data on cohorts large enough to compare rates of stent...

Second-generation drug-eluting stents. Moving the field forward.

Second versus first generation drug eluting stents during stent overexpansion.

Nitric-oxide coated bioactive titanium stents: safer and more effective than second-generation drug-eluting stents?

Polymer-coated drug-eluting stents (DESs) have become the treatment of choice in most patients undergoing percutaneous coronary interventions. Although these stents are effective in the sense that they reduce the restenosis rate and the need for repeat intervention by 70% compared with bare-metal stents, concerns have been raised about a series of risks closely related to the metal mesh of the ...